976 related articles for article (PubMed ID: 17202584)
1. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
Cheng J; Grande JP
Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.
Lugnier C
Pharmacol Ther; 2006 Mar; 109(3):366-98. PubMed ID: 16102838
[TBL] [Abstract][Full Text] [Related]
4. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M
Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
[TBL] [Abstract][Full Text] [Related]
5. Lixazinone stimulates mitogenesis of Madin-Darby canine kidney cells.
Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Zhou W; Grande JP
Exp Biol Med (Maywood); 2006 Mar; 231(3):288-95. PubMed ID: 16514175
[TBL] [Abstract][Full Text] [Related]
6. Targeting cancer with phosphodiesterase inhibitors.
Savai R; Pullamsetti SS; Banat GA; Weissmann N; Ghofrani HA; Grimminger F; Schermuly RT
Expert Opin Investig Drugs; 2010 Jan; 19(1):117-31. PubMed ID: 20001559
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic sites and comparison with other cyclic AMP-binding proteins.
Butt E; Beltman J; Becker DE; Jensen GS; Rybalkin SD; Jastorff B; Beavo JA
Mol Pharmacol; 1995 Feb; 47(2):340-7. PubMed ID: 7870042
[TBL] [Abstract][Full Text] [Related]
8. Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel.
Lugnier C; Keravis T; Eckly-Michel A
J Physiol Pharmacol; 1999 Dec; 50(4):639-52. PubMed ID: 10639014
[TBL] [Abstract][Full Text] [Related]
9. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
Netherton SJ; Maurice DH
Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
[TBL] [Abstract][Full Text] [Related]
11. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
[TBL] [Abstract][Full Text] [Related]
12. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
Gupta R; Kumar G; Kumar RS
Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP-dependent Cl secretion is regulated by multiple phosphodiesterase subtypes in human colonic epithelial cells.
O'Grady SM; Jiang X; Maniak PJ; Birmachu W; Scribner LR; Bulbulian B; Gullikson GW
J Membr Biol; 2002 Jan; 185(2):137-44. PubMed ID: 11891572
[TBL] [Abstract][Full Text] [Related]
14. Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation.
Baxendale RW; Fraser LR
Mol Reprod Dev; 2005 Aug; 71(4):495-508. PubMed ID: 15856425
[TBL] [Abstract][Full Text] [Related]
15. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value?
Albrecht K; Uckert S; Oelke M; Andersson KE; Jonas U; Tröger HD; Hedlund P
J Forensic Leg Med; 2007 Jul; 14(5):270-4. PubMed ID: 17113813
[TBL] [Abstract][Full Text] [Related]
17. Cyclic nucleotide phosphodiesterases.
Essayan DM
J Allergy Clin Immunol; 2001 Nov; 108(5):671-80. PubMed ID: 11692087
[TBL] [Abstract][Full Text] [Related]
18. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells.
Kim NN; Huang Y; Moreland RB; Kwak SS; Goldstein I; Traish A
Mol Cell Biol Res Commun; 2000 Jul; 4(1):10-4. PubMed ID: 11152621
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular implications in the use of PDE5 inhibitor therapy.
Maurice DH
Int J Impot Res; 2004 Jun; 16 Suppl 1():S20-3. PubMed ID: 15224131
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5.
Schankin CJ; Kruse LS; Reinisch VM; Jungmann S; Kristensen JC; Grau S; Ferrari U; Sinicina I; Goldbrunner R; Straube A; Kruuse C
Headache; 2010 Mar; 50(3):431-41. PubMed ID: 19751368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
